This anti-aging pure retinol eye cream helps visibly reduce the appearance of crow’s feet, wrinkles, and dark circles. This unique formula provides an instant, visible lifting effect and is gentle enough for the sensitive eye area. REDERMIC Retinol Eye Cream is formulated with a unique complex of Pure Retinol and Timed-Release Retinol to provide the right dose with optimal efficacy and tolerance for sensitive skin.
Pure retinol is known as one of the most effective active ingredients in treating the signs of photoaging: deep wrinkles and age spots. Time-Release Retinol helps enhance the anti-aging corrective efficacy while respecting the tolerance threshold of sensitive skin.
Skin concern:
– Crow’s feet wrinkles.
– Dark circles.
– Visible signs of fatigue around the eye area.
– Sensitive skin and eyes
Skin type:
All skin types.
Benefits :
– Retinol eye cream visibly reduces the appearance of crow’s feet wrinkles.
– The refreshing gel texture provides an instant visible lifting effect.
– Helps visibly reduce the appearance of dark circles.
– Suitable for the sensitive eye area.
How to use:
Step 1: Apply at night. Massage from the inner corner of the eye outward.
Step 2: Use in conjunction with SPF protection daily.
Recommended for use at night.
If used in conjunction with a facial moisturizer, use the eye product first.
If your skin is sensitive during the first use, space out the applications.
As a precaution, avoid using products containing retinol during pregnancy and breastfeeding.
Aqua / Agua – Estearato de isoacetilo – Glicerina – Octyldodecanol – Propilenglicol – Pentylene Glicol – Dimeticona – Copolímero de acrilamida/acriloildimetiltaurato de sodio – Alcohol cetearílico – Crosspolymer de dimeticona/vinil dimeticona – Cafeína – Isohexadecano – Hialuronato de sodio – Hidróxido de sodio – Retinol – Linoleato de retinilo – Adenosina – Poliacrildimetiltauramida Amónica / Poliacriloildimetiltaurato Amónico – Glicol Caprilil – Ácido Cítrico – Polisilicona- 8 – Polisorbato 80 -Fenoxietanol.
Reviews
There are no reviews yet.